These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 18199532)
1. alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo. Hedlund M; Ng E; Varki A; Varki NM Cancer Res; 2008 Jan; 68(2):388-94. PubMed ID: 18199532 [TBL] [Abstract][Full Text] [Related]
2. The Inhibitory Role of α2,6-Sialylation in Adipogenesis. Kaburagi T; Kizuka Y; Kitazume S; Taniguchi N J Biol Chem; 2017 Feb; 292(6):2278-2286. PubMed ID: 28031460 [TBL] [Abstract][Full Text] [Related]
3. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Seales EC; Jurado GA; Brunson BA; Wakefield JK; Frost AR; Bellis SL Cancer Res; 2005 Jun; 65(11):4645-52. PubMed ID: 15930282 [TBL] [Abstract][Full Text] [Related]
4. α2,6-linked sialic acids on N-glycans modulate the adhesion of hepatocarcinoma cells to lymph nodes. Wang S; Chen X; Wei A; Yu X; Niang B; Zhang J Tumour Biol; 2015 Feb; 36(2):885-92. PubMed ID: 25304155 [TBL] [Abstract][Full Text] [Related]
5. Majority of alpha2,6-sialylated glycans in the adult mouse brain exist in O-glycans: SALSA-MS analysis for knockout mice of alpha2,6-sialyltransferase genes. Ohmi Y; Nishikaze T; Kitaura Y; Ito T; Yamamoto S; Sugiyama F; Matsuyama M; Takahashi Y; Takeda A; Kawahara T; Okajima T; Furukawa K; Furukawa K Glycobiology; 2021 Jun; 31(5):557-570. PubMed ID: 33242079 [TBL] [Abstract][Full Text] [Related]
6. Alpha2,6-sialylation of cell-surface N-glycans inhibits glioma formation in vivo. Yamamoto H; Oviedo A; Sweeley C; Saito T; Moskal JR Cancer Res; 2001 Sep; 61(18):6822-9. PubMed ID: 11559557 [TBL] [Abstract][Full Text] [Related]
7. Protein sialylation by sialyltransferase involves radiation resistance. Lee M; Lee HJ; Bae S; Lee YS Mol Cancer Res; 2008 Aug; 6(8):1316-25. PubMed ID: 18708363 [TBL] [Abstract][Full Text] [Related]
8. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma. Pousset D; Piller V; Bureaud N; Monsigny M; Piller F Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085 [TBL] [Abstract][Full Text] [Related]
9. Caveolin-1 facilitates cell migration by upregulating nuclear receptor 4A2/retinoid X receptor α-mediated β-galactoside α2,6-sialyltransferase I expression in human hepatocarcinoma cells. Chen X; Wang L; Yu X; Wang S; Zhang J Int J Biochem Cell Biol; 2021 Aug; 137():106027. PubMed ID: 34157397 [TBL] [Abstract][Full Text] [Related]
10. Cleavage of ST6Gal I by radiation-induced BACE1 inhibits golgi-anchored ST6Gal I-mediated sialylation of integrin β1 and migration in colon cancer cells. Lee M; Park JJ; Ko YG; Lee YS Radiat Oncol; 2012 Mar; 7():47. PubMed ID: 22449099 [TBL] [Abstract][Full Text] [Related]
11. Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation. Martin LT; Marth JD; Varki A; Varki NM J Biol Chem; 2002 Sep; 277(36):32930-8. PubMed ID: 12068010 [TBL] [Abstract][Full Text] [Related]
12. Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms. Shaikh FM; Seales EC; Clem WC; Hennessy KM; Zhuo Y; Bellis SL Exp Cell Res; 2008 Oct; 314(16):2941-50. PubMed ID: 18703050 [TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 up-regulates integrin α2,6-sialylation to promote integrin α5β1-dependent hepatocarcinoma cell adhesion. Yu S; Fan J; Liu L; Zhang L; Wang S; Zhang J FEBS Lett; 2013 Mar; 587(6):782-7. PubMed ID: 23416306 [TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory IgG production requires functional P1 promoter in β-galactoside α2,6-sialyltransferase 1 (ST6Gal-1) gene. Jones MB; Nasirikenari M; Lugade AA; Thanavala Y; Lau JT J Biol Chem; 2012 May; 287(19):15365-70. PubMed ID: 22427662 [TBL] [Abstract][Full Text] [Related]
15. miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1. Han Y; Liu Y; Fu X; Zhang Q; Huang H; Zhang C; Li W; Zhang J J Physiol Biochem; 2018 Aug; 74(3):491-501. PubMed ID: 30006781 [TBL] [Abstract][Full Text] [Related]
16. N-linked α2,6-sialylation of integrin β1 by the sialyltransferase ST6Gal1 promotes cell proliferation and stemness in gestational trophoblastic disease. Liu J; Dong X; Xie R; Tang Y; Thomas AM; Li S; Liu S; Yu M; Qin H Placenta; 2024 Apr; 149():18-28. PubMed ID: 38490094 [TBL] [Abstract][Full Text] [Related]
17. Mouse ST6Gal sialyltransferase gene expression during mammary gland lactation. Dalziel M; Huang RY; Dall'Olio F; Morris JR; Taylor-Papadimitriou J; Lau JT Glycobiology; 2001 May; 11(5):407-12. PubMed ID: 11425801 [TBL] [Abstract][Full Text] [Related]
18. Forced expression of α2,3-sialyltransferase IV rescues impaired heart development in α2,6-sialyltransferase I-deficient medaka. Omoto T; Wu D; Maruyama E; Tajima K; Hane M; Sato C; Kitajima K Biochem Biophys Res Commun; 2023 Mar; 649():62-70. PubMed ID: 36745971 [TBL] [Abstract][Full Text] [Related]
19. Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers. Lu J; Gu J Molecules; 2015 Apr; 20(5):7509-27. PubMed ID: 25919275 [TBL] [Abstract][Full Text] [Related]
20. The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death. Amano M; Galvan M; He J; Baum LG J Biol Chem; 2003 Feb; 278(9):7469-75. PubMed ID: 12499376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]